Skip to main content
SleepCited

Prescription Drugs Used in Insomnia.

Sylvie Dujardin, Angelique Pijpers, Dirk Pevernagie
Review Sleep medicine clinics 2020 27 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D32386689'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
Chronic insomnia patients
Intervention
Prescription Drugs Used in Insomnia. None
Vergleichsgruppe
None
Primärer Endpunkt
None
Wirkungsrichtung
Mixed
Verzerrungsrisiko
Unclear

Abstract

The scope of this article is to review the effects on sleep of prescription drugs that are commonly prescribed for chronic insomnia in adults. The following groups are discussed: benzodiazepines and its receptor agonists, the dual orexin receptor antagonist suvorexant, melatonin and its receptor agonists, sedating antidepressants, and antipsychotics. Together with the neurobiologic and pharmacologic properties of these drugs, clinical effects are described, including subjective and objective effects on sleep duration, continuity, and architecture. Medical prescription information is given when available. Recently published American and European guidelines for the treatment of insomnia serve as reference frame.

Zusammenfassung

The effects on sleep of prescription drugs that are commonly prescribed for chronic insomnia in adults, including benzodiazepines and its receptor agonists, the dual orexin receptor antagonist suvorexant, melatonin, sedating antidepressants, and antipsychotics are reviewed.

Used In Evidence Reviews

Similar Papers